Clincosm LogoSign in Get a demo

Pancreatic Adenocarcinoma

Showing 76 - 100 of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Pancreas Cancer Trial in Roma, Rome (EUS-guided laser ablation)

Terminated
  • Pancreatic Adenocarcinoma
  • Pancreas Cancer
  • EUS-guided laser ablation
  • Roma, RM, Italy
  • +1 more
Feb 10, 2022

Pancreatic Adenocarcinoma Trial in United States (batiraxcept, Nab paclitaxel, Gemcitabine)

Recruiting
  • Pancreatic Adenocarcinoma
  • Santa Monica, California
  • +16 more
Feb 21, 2022

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022

Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Scottsdale (Paclitaxel Protein

Active, not recruiting
  • Resectable Pancreatic Cancer
  • +3 more
  • Paclitaxel Protein Bound (Abraxane)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 15, 2022

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

Active, not recruiting
  • Pancreatic Cancer
  • +4 more
  • Paricalcitol (Zemplar)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 16, 2022

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7 Trial in Omaha (drug, other,

Recruiting
  • Pancreatic Adenocarcinoma
  • +9 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 14, 2022

Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma Trial in China (AB011 Injection)

Recruiting
  • Solid Tumor
  • +2 more
  • AB011 Injection
  • Hefei, Anhui, China
  • +11 more
Feb 7, 2022

PD-L1 in Pancreatic Ductal Adenocarcinoma

Recruiting
  • Pancreatic Adenocarcinoma
    • Sohag, Egypt
      Faculty of Medicine, Sohag University
    Jan 27, 2022

    Pancreatic Adenocarcinoma Trial in Manchester (Portal vein sampling)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Portal vein sampling
    • Manchester, United Kingdom
    • +1 more
    Feb 1, 2022

    Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Pancreatic Cancer Non-resectable
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 24, 2022

    Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

    Active, not recruiting
    • Colon Carcinoma Metastatic in the Liver
    • +13 more
    • Anti-SEMA4D Monoclonal Antibody VX15/2503
    • +3 more
    • Atlanta, Georgia
    • +3 more
    Dec 15, 2021

    Pancreatic Adenocarcinoma Trial in Evanston (5 Fluorouracil, Leucovorin, Irinotecan)

    Completed
    Has Results
    • Pancreatic Adenocarcinoma
    • 5 Fluorouracil
    • +3 more
    • Evanston, Illinois
      NorthShore University HealthSystem
    Nov 4, 2021

    Pancreatic Adenocarcinoma Trial in France (Gene Therapy product CYL-02, Gemcitabine)

    Active, not recruiting
    • Pancreatic Adenocarcinoma
    • Clichy, France
    • +6 more
    Oct 27, 2021

    Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

    Active, not recruiting
    • Pancreatic Adenocarcinoma
    • +6 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Oct 20, 2021

    Pancreatic Adenocarcinoma Trial in Louisville (Nivolumab, Irreversible Electroporation)

    Active, not recruiting
    • Pancreatic Adenocarcinoma
    • Louisville, Kentucky
      University of Louisville
    Oct 6, 2021

    Pancreatic Cancer, Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in New York, Charlottesville

    Active, not recruiting
    • Pancreatic Cancer
    • +3 more
    • anti-EGFR-bispecific antibody armed activated T-cells
    • New York, New York
    • +1 more
    Oct 7, 2021

    Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in Portland (drug, radiation, other, procedure)

    Active, not recruiting
    Has Results
    • Pancreatic Adenocarcinoma
    • Resectable Pancreatic Carcinoma
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Sep 2, 2021

    Pancreatic Adenocarcinoma Trial in Columbus (Anesthesia Procedure, General Anesthesia Procedure, Resection)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Anesthesia Procedure
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 28, 2021

    Pancreatic Adenocarcinoma Trial in Verona (Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid
    • Verona, Italy
      Centro Ricerche Cliniche
    Jul 27, 2021

    Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab-paclitaxel)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Seattle, Washington
      Virginia mason medical Center
    Jul 19, 2021

    Pancreatic Adenocarcinoma Trial in Louisville (Nestle IMPACT Advanced Recovery, Nestle Boost High Protein Drink)

    Terminated
    • Pancreatic Adenocarcinoma
    • Nestle IMPACT Advanced Recovery
    • Nestle Boost High Protein Drink
    • Louisville, Kentucky
      University of Louisville
    Jul 10, 2021

    Pancreatic Adenocarcinoma Trial in Dallas (Nab-paclitaxel, Gemcitabine, Cisplatin)

    Completed
    • Pancreatic Adenocarcinoma
    • Dallas, Texas
      Baylor Charles A. Sammons Cancer Center
    Jun 21, 2021

    Pancreatic Adenocarcinoma Trial in Dallas (Anakinra)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Dallas, Texas
      Baylor University Medical Center, Charles A Sammons Cancer Cente
    Jun 8, 2021

    Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,

    Recruiting
    • Pancreatic Adenocarcinoma
    • +2 more
    • Chicago, Illinois
      The University of Chicago
    Jun 7, 2021